We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
- Authors
Braga-Basaria, Milena; Dobs, Adrian S; Muller, Denis C; Carducci, Michael A; John, Majnu; Egan, Josephine; Basaria, Shehzad
- Abstract
Prostate cancer (PCa) is one of the most common cancers in men. Men with recurrent or metastatic PCa are treated with androgen-deprivation therapy (ADT), resulting in profound hypogonadism. Because male hypogonadism is a risk factor for metabolic syndrome and men with PCa have high cardiovascular mortality, we evaluated the prevalence of metabolic syndrome in men undergoing long-term ADT.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 24, p3979
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.05.9741